相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap
Keita Hirai et al.
ALLERGY (2021)
RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target
Yanyan Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
Farshad Abedi et al.
CELL CYCLE (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Direct interaction analysis of microRNA-351-5p and nuclear scaffold lamin B1 mRNA by the cell-free in vitro mRNA/miRNA binding evaluation system
Akira Sato et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Wanchao Yin et al.
SCIENCE (2020)
Hopes rise for coronavirus drug remdesivir
Heidi Ledford
NATURE (2020)
Structure of replicating SARS-CoV-2 polymerase
Hauke S. Hillen et al.
NATURE (2020)
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection
Muserref Duygu Sacar Demirci et al.
PEERJ (2020)
Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting
Ali Hosseini Rad S M et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19
Md. Abdullah-Al-Kamran Khan et al.
FRONTIERS IN GENETICS (2020)
Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase
Leili Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities
Elif Damla Arisan et al.
VIRUSES-BASEL (2020)
Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium
Jonathan Tak-Sum Chow et al.
GENES (2020)
Genomics functional analysis and drug screening of SARS-CoV-2
Long Chen et al.
GENES & DISEASES (2020)
Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2
Woo Ryung Kim et al.
MOLECULES AND CELLS (2020)
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
Alexandro Guterres et al.
INFECTION GENETICS AND EVOLUTION (2020)
Nidovirus RNA polymerases: Complex enzymes handling exceptional RNA genomes
Clara C. Posthuma et al.
VIRUS RESEARCH (2017)
SARS-CoV ORF1b-encoded nonstructural proteins 12-16: Replicative enzymes as antiviral targets
Lorenzo Subissi et al.
ANTIVIRAL RESEARCH (2014)
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Rolf Hilgenfeld et al.
ANTIVIRAL RESEARCH (2013)
MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region
Linlin Wang et al.
ANTIVIRAL RESEARCH (2012)
Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells
Liping Song et al.
JOURNAL OF VIROLOGY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR
J. Robin Lytle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)